Presence of a SARS-COV-2 protein enhances Amyloid Formation of Serum Amyloid A

A marker for the severeness and disease progress of COVID-19 is overexpression of serum amyloid A (SAA) to levels that in other diseases are associated with a risk for SAA amyloidosis. In order to understand whether SAA amyloidosis could also be a long-term risk of SARS-COV-2 infections we have used...

Descripción completa

Detalles Bibliográficos
Autores principales: Jana, Asis K., Greenwood, Augustus B., Hansmann, Ulrich H. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142650/
https://www.ncbi.nlm.nih.gov/pubmed/34031653
http://dx.doi.org/10.1101/2021.05.18.444723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142650/
https://www.ncbi.nlm.nih.gov/pubmed/34031653
http://dx.doi.org/10.1101/2021.05.18.444723

Ejemplares similares